JPRN-UMIN000031742招募中未知
Efficacy of systemic venous sampling of FGF23 to localize responsible tumors in tumor-induced rickets/osteomalacia - Efficacy of systemic venous sampling of FGF23
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with serious kidney disease(eGFR<30 mL/min/1.73m2). Patients who are pregnant. Patients who are considered ineligible for the study by investigators' decision.
研究者
相似试验
招募中
不适用
The investigation of FGF23, a prognostic factor in children with chronic kidney disease and bone metabolismChronic kidney diseaseJPRN-UMIN000028891Osaka Women's and Children's Hospital200
进行中（未招募）
1 期
A Phase 3b Open-label Study of the Anti-FGF23 Antibody, Burosumab (KRN23) in Adult Patients with X-linked Hypophosphatemia (XLH)EUCTR2018-000202-37-GBKyowa Kirin Pharmaceutical Development Ltd40
进行中（未招募）
1 期
A Phase 3b Open-label Study of the Anti-FGF23 Antibody, Burosumab (KRN23) in Adult Patients with X-linked Hypophosphatemia (XLH)XLH is a rare, genetic disorder that is serious, chronically debilitating and represents an unmet medical need. This genetic deficiency is estimated to occur in about 1:20,000 live births (Burnett et al. 1964), (Imel et al. 2005). XLH is the most common inherited form of rickets and the most common inherited defect in renal tubular phosphate transport. XLH is transmitted as an X-linked dominant disorder (Dixon et al. 1998)MedDRA version: 20.0Level: LLTClassification code 10016206Term: Familial hypophosphataemic ricketsSystem Organ Class: 100000004850EUCTR2018-000202-37-ITKyowa Kirin Pharmaceutical Development Limited50
进行中（未招募）
1 期
A Phase 3b Open-label Study of the Anti-FGF23 Antibody, Burosumab (KRN23) in Adult Patients with X-linked Hypophosphatemia (XLH)EUCTR2018-000202-37-FRKyowa Kirin Pharmaceutical Development Ltd40
已完成
4 期
SoFT - Sevelamer on FGF23 Trial - A clinical trial assessing the quantitative effect of phosphate binding therapy on FGF23.cardiovascular disease in chronic kidney disease1001329610038430NL-OMON41487Vrije Universiteit Medisch Centrum60